Security key
00166B105
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)
CUSIP: 00166B105
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 133,751,136
- Total 13F shares
- 35,930,829
- Share change
- -838,662
- Total reported value
- $290,675,201
- Put/Call ratio
- 0.74%
- Price per share
- $8.09
- Number of holders
- 92
- Value change
- -$16,579,357
- Number of buys
- 52
- Number of sells
- 37
Report period
Q2 2022
Institutions
92
Top holders
10
ALXO full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
ALX ONCOLOGY HOLDINGS INC SEC filings
ALX ONCOLOGY HOLDINGS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00166B105
Recent filing periods:
Top shareholders of ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13F
Large-stake signal
No latest 13D/G holder appears in this grouped view.
Evidence coverage
50 holder rows
Latest evidence as of 31 Mar 2022.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| venBio Partners LLC |
13F
Company
|
7.3%
|
$163,929,000
9,699,925 shares
|
— | 31 Mar 2022 |
| Vivo Capital, LLC |
13F
Company
|
3.2%
|
$71,319,000
4,220,048 shares
|
— | 31 Mar 2022 |
| FMR LLC |
13F
Company
|
2.7%
|
$60,147,000
3,558,954 shares
|
— | 31 Mar 2022 |
| Logos Global Management LP |
13F
Company
|
2.3%
|
$50,892,000
3,011,352 shares
|
— | 31 Mar 2022 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.1%
|
$47,486,000
2,809,826 shares
|
— | 31 Mar 2022 |
| STATE STREET CORP |
13F
Company
|
1.6%
|
$36,060,000
2,133,744 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$28,318,000
1,675,656 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
1%
|
$22,907,000
1,355,478 shares
|
— | 31 Mar 2022 |
| Redmile Group, LLC |
13F
Company
|
0.58%
|
$13,054,000
772,397 shares
|
— | 31 Mar 2022 |
| Cormorant Asset Management, LP |
13F
Company
|
0.53%
|
$12,034,000
712,079 shares
|
— | 31 Mar 2022 |
| Invesco Ltd. |
13F
Company
|
0.48%
|
$10,875,000
643,487 shares
|
— | 31 Mar 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.46%
|
$10,507,000
621,700 shares
|
— | 31 Mar 2022 |
| Artal Group S.A. |
13F
Company
|
0.37%
|
$8,450,000
500,000 shares
|
— | 31 Mar 2022 |
| Pier Capital, LLC |
13F
Company
|
0.29%
|
$6,666,000
394,443 shares
|
— | 31 Mar 2022 |
| MORGAN STANLEY |
13F
Company
|
0.29%
|
$6,497,000
384,515 shares
|
— | 31 Mar 2022 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
Company
|
0.27%
|
$6,179,535
365,653 shares
|
— | 31 Mar 2022 |
| DEUTSCHE BANK AG\ |
13F
Company
|
0.26%
|
$5,807,000
343,663 shares
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.24%
|
$5,413,000
320,341 shares
|
— | 31 Mar 2022 |
| Samsara BioCapital, LLC |
13F
Company
|
0.2%
|
$4,441,000
262,786 shares
|
— | 31 Mar 2022 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.16%
|
$3,625,000
214,486 shares
|
— | 31 Mar 2022 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
Company
|
0.16%
|
$3,597,000
212,837 shares
|
— | 31 Mar 2022 |
| NORTHERN TRUST CORP |
13F
Company
|
0.13%
|
$2,935,000
173,677 shares
|
— | 31 Mar 2022 |
| Rafferty Asset Management, LLC |
13F
Company
|
0.12%
|
$2,651,000
156,876 shares
|
— | 31 Mar 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.11%
|
$2,515,000
148,800 shares
|
— | 31 Mar 2022 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.11%
|
$2,486,000
147,095 shares
|
— | 31 Mar 2022 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.1%
|
$2,265,000
134,030 shares
|
— | 31 Mar 2022 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.1%
|
$2,256,000
133,479 shares
|
— | 31 Mar 2022 |
| Ensign Peak Advisors, Inc |
13F
Company
|
0.1%
|
$2,154,000
127,432 shares
|
— | 31 Mar 2022 |
| AXA S.A. |
13F
Company
|
0.09%
|
$2,098,963
124,199 shares
|
— | 31 Mar 2022 |
| TWO SIGMA ADVISERS, LP |
13F
Company
|
0.08%
|
$1,906,000
112,800 shares
|
— | 31 Mar 2022 |
| UBS Group AG |
13F
Company
|
0.06%
|
$1,455,000
86,072 shares
|
— | 31 Mar 2022 |
| Bank of New York Mellon Corp |
13F
Company
|
0.06%
|
$1,252,000
74,083 shares
|
— | 31 Mar 2022 |
| Tekla Capital Management LLC |
13F
Company
|
0.05%
|
$1,119,000
66,211 shares
|
— | 31 Mar 2022 |
| Russell Investments Group, Ltd. |
13F
Company
|
0.05%
|
$1,030,000
61,000 shares
|
— | 31 Mar 2022 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.04%
|
$992,000
58,681 shares
|
— | 31 Mar 2022 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.04%
|
$936,000
55,412 shares
|
— | 31 Mar 2022 |
| FEDERATED HERMES, INC. |
13F
Company
|
0.04%
|
$914,000
54,107 shares
|
— | 31 Mar 2022 |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
Company
|
0.04%
|
$865,000
51,200 shares
|
— | 31 Mar 2022 |
| Cubist Systematic Strategies, LLC |
13F
Company
|
0.04%
|
$857,000
50,694 shares
|
— | 31 Mar 2022 |
| Vident Investment Advisory, LLC |
13F
Company
|
0.04%
|
$847,000
50,123 shares
|
— | 31 Mar 2022 |
| Nuveen Asset Management, LLC |
13F
Company
|
0.04%
|
$872,000
48,626 shares
|
— | 31 Mar 2022 |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
Company
|
0.03%
|
$736,000
43,548 shares
|
— | 31 Mar 2022 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
0.03%
|
$709,000
41,950 shares
|
— | 31 Mar 2022 |
| ALPS ADVISORS INC |
13F
Company
|
0.03%
|
$706,000
41,764 shares
|
— | 31 Mar 2022 |
| Jump Financial, LLC |
13F
Company
|
0.03%
|
$664,000
39,300 shares
|
— | 31 Mar 2022 |
| SG Americas Securities, LLC |
13F
Company
|
0.03%
|
$594,000
35,126 shares
|
— | 31 Mar 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
0.03%
|
$575,000
34,032 shares
|
— | 31 Mar 2022 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
0.02%
|
$556,000
32,900 shares
|
— | 31 Mar 2022 |
| Financial Advisory Group |
13F
Company
|
0.02%
|
$531,000
31,417 shares
|
— | 31 Mar 2022 |
| CITIGROUP INC |
13F
Company
|
0.02%
|
$426,000
25,183 shares
|
— | 31 Mar 2022 |
Institutional Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q2 2022
As of 30 Jun 2022,
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,930,829 shares.
The largest 10 holders included
venBio Partners LLC, Vivo Capital, LLC, FMR LLC, Logos Global Management LP, ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, and Cormorant Asset Management, LP.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
94
Q2 2022 holders
92
Holder diff
-2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.